共 50 条
Treatment of urinary incontinence
被引:1
|作者:
Rovner E.S.
[1
]
机构:
[1] Division of Urology, Department of Surgery, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, 19104, PA
关键词:
Oxybutynin;
Stress Urinary Incontinence;
Tolterodine;
Urge Incontinence;
Urinary Incontinence;
D O I:
10.1007/s11934-000-0024-2
中图分类号:
学科分类号:
摘要:
The treatment of urinary incontinence is a dynamic and evolving field. New therapies, techniques, and procedures, as well as some subtle refinements in treatments currently used, offer hope for the millions of people suffering from this condition. Recent attention has been directed toward reevaluating the efficacy and durability of some standard treatments for stress urinary incontinence, including pelvic floor exercise, bladder neck suspensions, and pubovaginal slings. Occlusive or supportive devices have evolved into a suitable alternative in some patients. Extracorporeal magnetic therapy and alternative periurethral injectable agents may offer additional treatment strategies for the relief of symptomatic stress urinary incontinence. New drugs for the treatment of overactive bladder and urge urinary incontinence have been introduced recently and, in combination with neuromodulation, offer the first new treatments for this condition in over 25 years. Yet, as rapidly as new therapies become available for the treatment of urinary incontinence, problems have become evident with some that were introduced just a short time ago. Thus, cautious skepticism regarding these “new and improved” treatments should be maintained until long-term data become available with respect to safety, efficacy, and durability. © 2000, Current Science Inc.
引用
收藏
页码:235 / 244
页数:9
相关论文